These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 24040438

  • 1. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
    Zhang HH, Zhang ZY, Che CL, Mei YF, Shi YZ.
    Int J Clin Exp Pathol; 2013; 6(9):1734-46. PubMed ID: 24040438
    [Abstract] [Full Text] [Related]

  • 2. Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell.
    Xu CZ, Shi RJ, Chen D, Sun YY, Wu QW, Wang T, Wang PH.
    Int J Clin Exp Pathol; 2013; 6(12):2745-56. PubMed ID: 24294361
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
    Xu CZ, Xie J, Jin B, Chen XW, Sun ZF, Wang BX, Dong P.
    Int J Clin Exp Pathol; 2013; 6(7):1351-61. PubMed ID: 23826416
    [Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells.
    Ikeda R, Vermeulen LC, Lau E, Jiang Z, Sachidanandam K, Yamada K, Kolesar JM.
    Int J Oncol; 2011 Feb; 38(2):513-9. PubMed ID: 21152861
    [Abstract] [Full Text] [Related]

  • 6. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A.
    Bian WG, Zhou XN, Song S, Chen HT, Shen Y, Chen P.
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):649-659. PubMed ID: 30720173
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
    Hu S, Yuan Y, Song Z, Yan D, Kong X.
    Cell Physiol Biochem; 2018 Jan; 51(6):2509-2522. PubMed ID: 30557872
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.
    Dhayat SA, Mardin WA, Seggewiß J, Ströse AJ, Matuszcak C, Hummel R, Senninger N, Mees ST, Haier J.
    PLoS One; 2015 Jan; 10(11):e0143755. PubMed ID: 26606261
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potent effect of adenoviral vector expressing short hairpin RNA targeting ribonucleotide reductase large subunit M1 on cell viability and chemotherapeutic sensitivity to gemcitabine in non-small cell lung cancer cells.
    Tokunaga Y, Liu D, Nakano J, Zhang X, Nii K, Go T, Huang CL, Yokomise H.
    Eur J Cancer; 2015 Nov; 51(16):2480-9. PubMed ID: 26254808
    [Abstract] [Full Text] [Related]

  • 12. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
    Zhang S, Chang YY, Gong YW, Gao YJ, Guo Q, Wang YH, Zhao YL, Wang ZP.
    J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549
    [Abstract] [Full Text] [Related]

  • 13. microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.
    Liu Y, Miao L, Ni R, Zhang H, Li L, Wang X, Li X, Wang J.
    Oncol Rep; 2016 Dec; 36(6):3529-3535. PubMed ID: 27748920
    [Abstract] [Full Text] [Related]

  • 14. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
    Yang C, Xu M, Shen HJ, Zhu HY, Li F, He M, Chen T, Wang J, Shi WJ, Ji F.
    Int J Clin Exp Pathol; 2014 Dec; 7(2):521-8. PubMed ID: 24551272
    [Abstract] [Full Text] [Related]

  • 15. miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.
    Cao J, Wang Q, Wu G, Li S, Wang Q.
    Int Urol Nephrol; 2018 Oct; 50(10):1811-1819. PubMed ID: 30117016
    [Abstract] [Full Text] [Related]

  • 16. [Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line].
    Dong M, Feng FY, Lin C, Zhang XY, Fu M, Liang X, Zha YY, Lu HY, Wu M.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):323-8. PubMed ID: 15059518
    [Abstract] [Full Text] [Related]

  • 17. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
    Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, Zhang X, Huang Y, Zhang R, Wei J, Ali DW, Michalak M, Chen XZ, Tang J.
    Mol Cancer; 2020 Jul 29; 19(1):118. PubMed ID: 32727463
    [Abstract] [Full Text] [Related]

  • 18. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
    Shen Y, Pan Y, Xu L, Chen L, Liu L, Chen H, Chen Z, Meng Z.
    Tumour Biol; 2015 Jun 29; 36(6):4525-34. PubMed ID: 25722110
    [Abstract] [Full Text] [Related]

  • 19. miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.
    Okamoto K, Miyoshi K, Murawaki Y.
    PLoS One; 2013 Jun 29; 8(10):e77623. PubMed ID: 24147037
    [Abstract] [Full Text] [Related]

  • 20. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
    Denlinger CE, Rundall BK, Keller MD, Jones DR.
    Ann Thorac Surg; 2004 Oct 29; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.